Publications by authors named "Yong-An Shi"

Unlabelled: The hyaluronic acid capsule is crucial in protecting group A (GAS) against phagocytic killing. However, there have been reported outbreaks caused by capsule-deficient GAS strains, and the mechanisms underlying their evasion of immune clearance remain unclear. This study demonstrated that the capsule-deficient mutant [Cap(-)] of the strain increased survival within phagocytic cells compared to the wild-type strain [Cap(+)].

View Article and Find Full Text PDF

Extracellular vesicles (EVs) can be released from gram-positive bacteria and would participate in the delivery of bacterial toxins. (group A , GAS) is one of the most common pathogens of monomicrobial necrotizing fasciitis. Spontaneous inactivating mutation in the CovR/CovS two-component regulatory system is related to the increase of EVs production via an unknown mechanism.

View Article and Find Full Text PDF

RopB is a quorum-sensing regulator that binds to the SpeB-inducing peptide (SIP) under acidic conditions. SIP is known to be degraded by the endopeptidase PepO, whose transcription is repressed by the CovR/CovS two-component regulatory system. Both SIP-bound RopB (RopB-SIP) and SIP-free RopB (apo-RopB) can bind to the promoter; however, only RopB-SIP activates transcription.

View Article and Find Full Text PDF
Article Synopsis
  • Group A Streptococcus (GAS) uses a unique combination of two proteins, NADase and Streptolysin O (SLO), to enhance its ability to cause disease.
  • Researchers used advanced techniques like X-ray crystallography and small-angle scattering to unveil the structure and function of the NADase/SLO complex, focusing on how these proteins interact at an atomic level.
  • Their findings highlight the significance of a specific salt-bridge interaction between NADase and SLO, which is crucial for GAS's virulence and survival against the host's immune responses, validated through experiments in mice.
View Article and Find Full Text PDF

Necrotizing fasciitis is a severe infectious disease that results in significant mortality. Streptococcus pyogenes (group A Streptococcus, GAS) is one of the most common bacterial pathogens of monomicrobial necrotizing fasciitis. The early diagnosis of necrotizing fasciitis is crucial; however, the typical cutaneous manifestations are not always presented in patients with GAS necrotizing fasciitis, which would lead to miss- or delayed diagnosis.

View Article and Find Full Text PDF

The acquisition of the phage-encoded superantigen by scarlet fever-associated group A (, GAS) is found in North Asia. Nonetheless, the impact of acquiring by GAS in invasive infections is unclear. This study initially analyzed the prevalence of + GAS among isolates from sterile tissues and blood.

View Article and Find Full Text PDF

Severe manifestations of group A (GAS) infections are associated with massive tissue destruction and high mortality. Clindamycin (CLI), a bacterial protein synthesis inhibitor, is recommended for treating patients with severe invasive GAS infection. Nonetheless, the subinhibitory concentration of CLI induces the production of GAS virulent exoproteins, such as streptolysin O (SLO) and NADase, which would enhance bacterial virulence and invasiveness.

View Article and Find Full Text PDF
Article Synopsis
  • Group A streptococci (GAS) with mutations in the CovR/CovS system are more invasive and linked to severe infections, with the ability to survive inside phagocytic cells.
  • In experiments, capsule-deficient (cap) GAS mutants showed better survival and caused more damage in phagocytic cells compared to their encapsulated and wild-type counterparts.
  • The study highlights that targeting intracellular GAS with treatments like clindamycin is more effective in reducing bacterial toxicity than using penicillin, suggesting the importance of addressing these intracellular forms to prevent severe infections.
View Article and Find Full Text PDF

Bone defects represent a major clinical and socioeconomic problem without suitable treatment options. Previous studies have shown that transforming growth factor β1 (TGF‑β1) is important in the development of various diseases. The present study aimed to investigate the therapeutic potential of rabbit bone marrow‑derived mesenchymal stem cells (BMSCs) expressing TGF‑β1 in the treatment of rabbit femoral defects.

View Article and Find Full Text PDF